申请人:F. Hoffmann-La Roche AG
公开号:EP2301625A2
公开(公告)日:2011-03-30
Use of selective antagonists of the 5-HT6 receptor and 5-HT2A receptors for the preparation of medicaments and corresponding pharmaceutical compositions useful for the treatment of cognitive disorders are presented.
介绍了如何利用 5-HT6 受体和 5-HT2A 受体的选择性拮抗剂来制备治疗认知障碍的药物和相应的药物组合物。